NASDAQ: SKYE · Life Sciences · 6 alerts · CIK 1516551
Share price
$1.07Close, Nov 16
Market cap
$4.71M
Shares outstanding
4.42MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Skye Bioscience, Inc. filings on SEC EDGAR ↗
Skye Bioscience reported a significant decrease in cash and short-term investments from $25.7 million at year-end 2025 to $4.8 million as of September 30, 2026. The company experienced a net loss of $23.2 million for the first nine months of 2026, driven primarily by $13.2 million in research and development expenses. A 1-for-8 reverse stock split was effected on August 24, 2026.
Skye Bioscience received a unanimous jury verdict in its favor following a retrial in the U.S. District Court for the Central District of California. The lawsuit, filed by a former employee, alleged whistleblower protection violations and retaliation related to events occurring between 2018 and 2019. The verdict clears the company of all claims, though the plaintiff retains the right to file post-trial motions or appeals.
Skye Bioscience Director Andrew J. Schwab Sells $230K of Stock
Andrew J. Schwab, Director, sold 142,463 shares of Skye Bioscience, Inc. at $1.61 to $1.65 a share (average $1.62) in 2 transactions, worth $230K in total between Sep 22, 2026 and Sep 23, 2026. Shares held after the trade: 0 (-100.0%).
Skye Bioscience 10% Owner 5AM Partners VII LLC Sells $230K of Stock
5AM Partners VII LLC, 10% Owner, sold 142,463 shares of Skye Bioscience, Inc. at $1.61 to $1.65 a share (average $1.62) in 2 transactions, worth $230K in total between Sep 22, 2026 and Sep 23, 2026. Shares held after the trade: 0 (-100.0%).
Skye Bioscience Director Andrew J. Schwab Sells $62.3K of Stock
Andrew J. Schwab, Director, sold 32,607 shares of Skye Bioscience, Inc. at $1.91 a share, worth $62.3K in total on Sep 16, 2026. Shares held after the trade: 142,463 (-18.6%).
Skye Bioscience 10% Owner 5AM Partners VII LLC Sells $62.3K of Stock
5AM Partners VII LLC, 10% Owner, sold 32,607 shares of Skye Bioscience, Inc. at $1.91 a share, worth $62.3K in total on Sep 16, 2026. Shares held after the trade: 142,463 (-18.6%).